Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 426

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

Open access
on behalf of the NAIMS Cooperative, Sati, Pascal, Oh, Jiwon, Constable, R. Todd, Evangelou, Nikos, Guttmann, Charles R. G., Henry, Roland G., Klawiter, Eric C., Mainero, Caterina, Massacesi, Luca, McFarland, Henry, Nelson, Flavia, Ontaneda, Daniel, Rauscher, Alexander, Rooney, William D., Samaraweera, Amal P. R., Shinohara, Russell T., Sobel, Raymond A., Solomon, Andrew J., Treaba, Constantina A., Wuerfel, Jens, Zivadinov, Robert, Sicotte, Nancy L., Pelletier, Daniel, Reich, Daniel S.·2016·Nature Reviews Neurology

Abstract

The central vein sign (CVS) has been proposed as a novel MRI biomarker to improve the accuracy and speed of multiple sclerosis (MS) diagnosis. This Consensus Statement from the NAIMS Cooperative provides a roadmap to help radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS. Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2016.166

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 426

Metadata

Authors
Cooperative, O. B. O. T. N., Sati, P., Oh, J., Constable, R. T., Evangelou, N., Guttmann, C. R. G., Henry, R. G., Klawiter, E. C., Mainero, C., Massacesi, L., McFarland, H., Nelson, F., Ontaneda, D., Rauscher, A., Rooney, W. D., Samaraweera, A. P. R., Shinohara, R. T., Sobel, R. A., Solomon, A. J., Treaba, C. A., Wuerfel, J., Zivadinov, R., Sicotte, N. L., Pelletier, D., & Reich, D. S.
Venue
Nature Reviews Neurology
Published
2016-11-11
Volume
12
Issue
12
Pages
714-722
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W2551398945
Cited by
426
References
62
FWCI
6.50
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. https://app.cochat.ai/papers/10.1038/nrneurol.2016.166
The paper
Cooperative, O. B. O. T. N., Sati, P., Oh, J., Constable, R. T., Evangelou, N., Guttmann, C. R. G., Henry, R. G., Klawiter, E. C., Mainero, C., Massacesi, L., McFarland, H., Nelson, F., Ontaneda, D., Rauscher, A., Rooney, W. D., Samaraweera, A. P. R., Shinohara, R. T., Sobel, R. A., Solomon, A. J., . . . Reich, D. S. (2016). The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature Reviews Neurology. https://doi.org/10.1038/nrneurol.2016.166

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.